secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001193125-26-179391
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health granted Nasdaq extension to May 15, 2026; announces 1-for-35 reverse stock split
--------------------------------------------------------------------------------

- Nasdaq Panel grants extension until May 15, 2026 to demonstrate compliance with $1.00 minimum bid price rule.
- Company must close at $1.00+ for at least 10 consecutive business days by May 15.
- Reverse stock split at 1-for-35 effective April 30, 2026; trading continues on Nasdaq under JAGX.
- Reverse split approved at April 20, 2026 special meeting; no fractional shares – cash in lieu.
- Panel retains jurisdiction until September 1, 2026; delisting risk persists if compliance not met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/d109088d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-179391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer